VMI

VHCP Management II Portfolio holdings

AUM $379M
This Quarter Return
+31.9%
1 Year Return
+424.39%
3 Year Return
+2,335.22%
5 Year Return
–
10 Year Return
–
AUM
$244M
AUM Growth
+$244M
Cap. Flow
-$10.1M
Cap. Flow %
-4.12%
Top 10 Hldgs %
93.11%
Holding
23
New
1
Increased
2
Reduced
4
Closed
3

Top Buys

1
XLRN
Acceleron Pharma Inc.
XLRN
$4.15M
2
RARX
Ra Pharmaceuticals, Inc. Common Stock
RARX
$3.89M
3
ASND icon
Ascendis Pharma
ASND
$2.53M

Top Sells

1
CLCD
CoLucid Pharmaceuticals, Inc.
CLCD
$5.79M
2
HRTX icon
Heron Therapeutics
HRTX
$5.32M
3
CTMX icon
CytomX Therapeutics
CTMX
$4.99M
4
ARCT icon
Arcturus Therapeutics
ARCT
$1.54M
5
SYRE icon
Spyre Therapeutics
SYRE
$1.52M

Sector Composition

1 Healthcare 91.7%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
AVXS
1
DELISTED
AveXis, Inc. Common Stock
AVXS
$78.7M 32.22%
1,035,657
– –
BCRX icon
2
BioCryst Pharmaceuticals
BCRX
$1.74B
$51M 20.87%
6,071,142
– –
ASND icon
3
Ascendis Pharma
ASND
$11.8B
$22.7M 9.3%
811,492
+90,340
+13% +$2.53M
PDSB icon
4
PDS Biotechnology
PDSB
$57.8M
$17.6M 7.21%
1,933,582
– –
RARX
5
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
$15.4M 6.32%
725,029
+182,529
+34% +$3.89M
BOLD
6
DELISTED
Audentes Therapeutics, Inc
BOLD
$7.82M 3.2%
458,882
– –
SIOX
7
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$6.42M 2.63%
429,590
– –
CTMX icon
8
CytomX Therapeutics
CTMX
$336M
$4.99M 2.04%
288,915
-288,916
-50% -$4.99M
XLRN
9
DELISTED
Acceleron Pharma Inc.
XLRN
$4.15M 1.7%
+156,880
New +$4.15M
AKTX
10
Akari Therapeutics
AKTX
$24.8M
$4.09M 1.67%
369,490
– –
ORKA
11
Oruka Therapeutics, Inc. Common Stock
ORKA
$554M
$2.75M 1.13%
1,078,932
– –
CHRS icon
12
Coherus Oncology, Inc. Common Stock
CHRS
$135M
$2.02M 0.82%
95,276
-34,353
-27% -$727K
STML
13
DELISTED
Stemline Therapeutics, Inc.
STML
$1.95M 0.8%
228,130
-87,850
-28% -$751K
LPCN icon
14
Lipocine
LPCN
$15.8M
$1.64M 0.67%
420,000
– –
KALV icon
15
KalVista Pharmaceuticals
KALV
$678M
$1.64M 0.67%
221,651
– –
OCRX
16
DELISTED
Ocera Therapeutics, Inc.
OCRX
$1.6M 0.65%
1,217,872
– –
ADVM icon
17
Adverum Biotechnologies
ADVM
$64.6M
$756K 0.31%
280,000
– –
ARCT icon
18
Arcturus Therapeutics
ARCT
$462M
$211K 0.09%
185,140
-1,352,323
-88% -$1.54M
SRRA
19
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$200K 0.08%
130,798
– –
HRTX icon
20
Heron Therapeutics
HRTX
$207M
– –
-405,901
Closed -$5.32M
SYRE icon
21
Spyre Therapeutics
SYRE
$996M
– –
-350,133
Closed -$1.52M
CLCD
22
DELISTED
CoLucid Pharmaceuticals, Inc.
CLCD
– –
-159,110
Closed -$5.79M